541 related articles for article (PubMed ID: 24998692)
1. Biochemical markers and MR imaging findings as predictors of crohn disease activity in patients scanned by contrast-enhanced MR enterography.
Quaia E; Cabibbo B; Sozzi M; Gennari AG; Pontello M; Degrassi F; Cova MA
Acad Radiol; 2014 Oct; 21(10):1225-32. PubMed ID: 24998692
[TBL] [Abstract][Full Text] [Related]
2. Impact of gadolinium-based contrast agent in the assessment of Crohn's disease activity: Is contrast agent injection necessary?
Quaia E; Sozzi M; Gennari AG; Pontello M; Angileri R; Cova MA
J Magn Reson Imaging; 2016 Mar; 43(3):688-97. PubMed ID: 26250897
[TBL] [Abstract][Full Text] [Related]
3. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
[TBL] [Abstract][Full Text] [Related]
4. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
Grazioli L; Morana G; Kirchin MA; Schneider G
Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced MR enterography as a stand-alone tool to evaluate Crohn's disease in a paediatric population.
Spieler B; Hindman N; Levy J; Zabrieski K; Sahlein D; Seuss C; Kim S
Clin Radiol; 2013 Oct; 68(10):1024-30. PubMed ID: 23796211
[TBL] [Abstract][Full Text] [Related]
6. MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease.
Laghi A; Paolantonio P; Iafrate F; Borrelli O; Dito L; Tomei E; Cucchiara S; Passariello R
Radiol Med; 2003; 106(1-2):18-27. PubMed ID: 12951547
[TBL] [Abstract][Full Text] [Related]
7. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
[TBL] [Abstract][Full Text] [Related]
8. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
Maccioni F; Bruni A; Viscido A; Colaiacomo MC; Cocco A; Montesani C; Caprilli R; Marini M
Radiology; 2006 Feb; 238(2):517-30. PubMed ID: 16371574
[TBL] [Abstract][Full Text] [Related]
9. Crohn's disease: small bowel motility impairment correlates with inflammatory-related markers C-reactive protein and calprotectin.
Bickelhaupt S; Pazahr S; Chuck N; Blume I; Froehlich JM; Cattin R; Raible S; Bouquet H; Bill U; Rogler G; Frei P; Boss A; Patak MA
Neurogastroenterol Motil; 2013 Jun; 25(6):467-73. PubMed ID: 23495824
[TBL] [Abstract][Full Text] [Related]
10. Visualization of the biliary tract using gadobenate dimeglumine: preliminary findings.
Ergen FB; Akata D; Sarikaya B; Kerimoglu U; Hayran M; Akhan O; Hussain HK
J Comput Assist Tomogr; 2008; 32(1):54-60. PubMed ID: 18303288
[TBL] [Abstract][Full Text] [Related]
11. Predictors of dysplastic nodule diagnosis in patients with liver cirrhosis on unenhanced and gadobenate dimeglumine-enhanced MRI with dynamic and hepatobiliary phase.
Quaia E; De Paoli L; Pizzolato R; Angileri R; Pantano E; Degrassi F; Ukmar M; Cova MA
AJR Am J Roentgenol; 2013 Mar; 200(3):553-62. PubMed ID: 23436844
[TBL] [Abstract][Full Text] [Related]
12. Performance of Surveillance MR Enterography (MRE) in Asymptomatic Children and Adolescents With Crohn's Disease.
Chu KF; Moran CJ; Wu K; Kaplan JL; Savarino JR; Board T; Israel EJ; Winter HS; Gee MS
J Magn Reson Imaging; 2019 Dec; 50(6):1955-1963. PubMed ID: 31145502
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn's disease.
Somwaru AS; Khanijow V; Katabathina VS
BMC Gastroenterol; 2019 Dec; 19(1):210. PubMed ID: 31805875
[TBL] [Abstract][Full Text] [Related]
14. Role of spectral presaturation attenuated inversion-recovery fat-suppressed T2-weighted MR imaging in active inflammatory bowel disease.
Udayasankar UK; Martin D; Lauenstein T; Rutherford R; Galloway J; Tudorascu D; Sitaraman SV
J Magn Reson Imaging; 2008 Nov; 28(5):1133-40. PubMed ID: 18972354
[TBL] [Abstract][Full Text] [Related]
15. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
16. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Bertin E; Luise A; Frego M; Plebani M; Sturniolo GC; D'Amico DF; Angriman I
Dis Colon Rectum; 2007 Jun; 50(6):861-9. PubMed ID: 17473939
[TBL] [Abstract][Full Text] [Related]
17. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma.
Kim TK; Lee KH; Jang HJ; Haider MA; Jacks LM; Menezes RJ; Park SH; Yazdi L; Sherman M; Khalili K
Radiology; 2011 Jun; 259(3):730-8. PubMed ID: 21364083
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
[TBL] [Abstract][Full Text] [Related]
20. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features.
Punwani S; Rodriguez-Justo M; Bainbridge A; Greenhalgh R; De Vita E; Bloom S; Cohen R; Windsor A; Obichere A; Hansmann A; Novelli M; Halligan S; Taylor SA
Radiology; 2009 Sep; 252(3):712-20. PubMed ID: 19635832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
